Moreover, 1-deoxynojirimycin, known for anti-hyperglycemic and anti-obesity effects, was found to increase glucose tolerance, insulin signaling and reduction of the white adipose tissue in HFD-fed mice [537]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.